Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-01-06 @ 9:38 PM
Study NCT ID:
NCT02263404
Status:
UNKNOWN
Last Update Posted:
2016-10-14
First Post:
2014-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PINS Stimulator System to Treat Severe Anorexia Nervosa
Sponsor:
Beijing Pins Medical Co., Ltd
Organization:
Study Overview
Official Title:
PINS Stimulator System to Treat Severe Anorexia Nervosa
Status:
UNKNOWN
Status Verified Date:
2016-08
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Anorexia Nervosa (AN) has the highest mortality of any psychiatric disorder and a paucity of effective treatments. AN becomes intractable in around 20%, resulting in huge individual and healthcare costs. The study will help patients with severe AN using DBS. Individuals with severe intractable AN will be eligible to take part in the study.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: